Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Cross Country Healthcare (CCRN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$18.60 | $19.00 | $17.00 | 52.71% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Cross Country Healthcare comes to $18.60. The forecasts range from a low of $17.00 to a high of $19.00. The average price target represents an increase of 52.71% from the last closing price of $12.18.
Analyst Price Targets (5 )
Broker Rating
Cross Country Healthcare currently has an average brokerage recommendation (ABR) of 2.25 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 2.25 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, three are Strong Buy, representing 37.5% of all recommendations. A month ago, Strong Buy represented 37.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.25 | 2.25 | 2.25 | 2.44 | 2.44 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/8/2024 | Not Identified | Not Identified | Hold | Hold |
8/15/2024 | UBS | Aj Rice | Hold | Hold |
8/8/2024 | Barrington Research | Kevin M Steinke | Strong Buy | Strong Buy |
8/1/2024 | William Blair | Trevor Romeo | Strong Buy | Strong Buy |
8/1/2024 | The Benchmark Company | William Sutherland | Strong Buy | Strong Buy |
8/1/2024 | Truist Securities | Tobey O'Brien Sommer | Hold | Hold |
5/2/2024 | Not Identified | Not Identified | Hold | Hold |
5/2/2024 | JMP Securities | Constantine Kyriakos Davides | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.25 |
ABR (Last week) | 2.25 |
# of Recs in ABR | 8 |
Average Target Price | $18.60 |
LT Growth Rate | 10.00% |
Industry | Staffing Firms |
Industry Rank by ABR | 191 of 252 |
Current Quarter EPS Est: | 0.10 |
CCRN FAQs
Cross Country Healthcare, Inc. (CCRN) currently has an average brokerage recommendation (ABR) of 2.25 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Cross Country Healthcare, Inc. (CCRN) is $18.60. The current on short-term price targets is based on 5 reports.
The forecasts for Cross Country Healthcare, Inc. (CCRN) range from a low of $17 to a high of $19. The average price target represents a increase of $50.85 from the last closing price of $12.33.
The current UPSIDE for Cross Country Healthcare, Inc. (CCRN) is 50.85%
Based on short-term price targets offered by five analysts, the average price target for Cross Country Healthcare comes to $18.60. The forecasts range from a low of $17.00 to a high of $19.00. The average price target represents an increase of 52.71% from the last closing price of $12.18.